Alchemab Therapeutics
Katarzyna Kmiecik is a Senior Scientist at Alchemab Therapeutics Ltd since June 2022, specializing in advanced research. Previously, Katarzyna completed a PhD at the University of Leicester from March 2017 to May 2022, focusing on T cell phenotype in CAR-mediated cytotoxicity under the iCASE BBSRC scholarship. Prior to that, a Senior Research Associate and Research Associate role at F-star Biotechnology Ltd. from March 2014 to March 2017 centered on Immuno-Oncology. Katarzyna also worked as a Research Assistant at the Laboratory of Experimental Pharmacology at the Jagiellonian Centre for Experimental Therapeutics from January 2012 to March 2014, contributing to a project on Vascular endothelium in lifestyle diseases. Katarzyna holds a Master's Degree in Biotechnology from Jagiellonian University, obtained from 2005 to 2010.
This person is not in any offices
Alchemab Therapeutics
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and development.